Sun Pharma Acquires Rights to Trademarks of 3 Diabetes Drug Brands in India from AstraZeneca

0
242

Sun Pharma has also acquired a patent license to manufacture and commercialise Dapagliflozin and Dapagliflozin with Metformin combination in India from AstraZeneca AB.